FDC LTD. - 531599 - Intimation Regarding Approval Received From US FDA For ANDA- Cefixime 400 Mg Tablets

FDC Ltd.

NSE: FDC | BSE: 531599 | ISIN: INE258B01022 | Industry: Pharmaceuticals
| Mid-range Performer

481.7500 6.35 (1.34%)

NSE Aug 04, 2025 15:31 PM

26.88% Fall from 52W High

Volume: 51,137

FDC Ltd.

18 Dec 2024

481.75

1.34%

Company Update

FDC LTD. - 531599 - Intimation Regarding Approval Received From US FDA For ANDA- Cefixime 400 …

BSE India

Intimation regarding approval received from US FDA for ANDA - Cefixime 400 mg tablets

More from FDC Ltd.

Recommended

IPO calendar fills up: 12 new issues, and 12 listings this week

| 04 Aug 2025, 03:44PM

Market trades higher, Narayana Hrudayalaya's Q1 revenue grows 12.4% YoY to Rs 1,507.3 crore

Trendlyne Marketwatch | 04 Aug 2025, 03:30PM

Five Interesting Stocks Today - August 1, 2025

The Baseline | 01 Aug 2025